Page last updated: 2024-08-21

dihydroergotamine and Abortion, Tubal

dihydroergotamine has been researched along with Abortion, Tubal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Albrecht, D; Bérard, A; Kori, S; Strom, S; Zhao, JP	1

Other Studies

1 other study(ies) available for dihydroergotamine and Abortion, Tubal

Article	Year
Dihydroergotamine and triptan use to treat migraine during pregnancy and the risk of adverse pregnancy outcomes. Scientific reports, 2021, 09-29, Volume: 11, Issue:1 Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adolescent; Adult; Case-Control Studies; Child; Child, Preschool; Dihydroergotamine; Female; Follow-Up Studies; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Migraine Disorders; Pregnancy; Premature Birth; Prospective Studies; Quebec; Tryptamines; Young Adult	2021

Article

Year

Dihydroergotamine and triptan use to treat migraine during pregnancy and the risk of adverse pregnancy outcomes.

Scientific reports, 2021, 09-29, Volume: 11, Issue:1

Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adolescent; Adult; Case-Control Studies; Child; Child, Preschool; Dihydroergotamine; Female; Follow-Up Studies; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Migraine Disorders; Pregnancy; Premature Birth; Prospective Studies; Quebec; Tryptamines; Young Adult

2021